tirzepatide approval F.D.A. Approves New Obesity Drug That Will Compete With Wegovy New Blockbuster Type 2 Medication

Enhanced skin elasticity and firmness

As researchers continue to explore the diverse benefits of GLP-1, including its therapeutic applications in gut inflammation and microbiome modulation, this hormone may play an even larger role in future digestive health strategies

The puffiness that accompanies excess weight and chronic inflammation recedes

Competitors: Why It Wins Feature Noom Hims & Hers Ro/Found Behavioral App CBT Gold Std Basic trackers Minimal Microdosing $199/mo No No Cost (No Ins.) $149-279 $199+ $99-250 Adherence 60%+ 75% (Hims data) ~50% Taper Guarantee Unique No No Edge : Psychology + meds = lasting change